1.
M Bjorkholm, B Fagrell, R Przybelski, N Winslow, M Young, RM Winslow. A phase I single blind clinical trial of a new oxygen transport agent (MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. haematol [Internet]. 2005Apr.1 [cited 2024Nov.22];90(4):505-1. Available from: https://haematologica.org/article/view/3482